glp-1 meds corona Diabetes: GLP-1s might shield lungs from long COVID damage My latest article for USA

N Engl J Med 2022;387(9):852854

M.BarnesA

We next evaluated the efficacy of I-M-150847 for blood glucose-lowering upon chronic treatment

Here's how a correctly built claim looks for an office visit with an injection: 99213-25 | M25.511 | E/M visit, shoulder pain evaluation 96372-59 | M25.511 | Toradol administration J1885 x 2 | M25.511 | Ketorolac 30 mg Each line has a job

Across patient records, the cough followed a recognizable pattern: Onset: Often developed weeks to months after starting GLP-1 therapy Duration: Frequently lasted longer than eight weeks, meeting criteria for chronic cough Clinical impact: Led to ENT referrals, reflux evaluations, asthma workups, and empiric treatments Clinical course: In some patients, cough-related visits decreased after stopping or switching therapy, although formal rechallenge data were limited Why Might GLP-1 Drugs Affect the Airway

Glucagon like peptide-1 (GLP-1) agonists and cardiometabolic protection: Historical development and future challenges